This idea is supported by the results of studies focusing on the role of NLGN2 in insulin secretion and on the potential of NLGN2 mimetics as tools for treating patients with diabetes (Munder et al, 2017; Munder et al, 2019). This evidence concerns the gene NLGN2 and diabetes mellitus.